Literature DB >> 10567548

Dissection of the LXXLL nuclear receptor-coactivator interaction motif using combinatorial peptide libraries: discovery of peptide antagonists of estrogen receptors alpha and beta.

C y Chang1, J D Norris, H Grøn, L A Paige, P T Hamilton, D J Kenan, D Fowlkes, D P McDonnell.   

Abstract

Recruitment of transcriptional coactivators following ligand activation is a critical step in nuclear receptor-mediated target gene expression. Upon binding an agonist, the receptor undergoes a conformational change which facilitates the formation of a specific coactivator binding pocket within the carboxyl terminus of the receptor. This permits the alpha-helical LXXLL motif within some coactivators to interact with the nuclear receptors. Until recently, the LXXLL motif was thought to function solely as a docking module; however, it now appears that sequences flanking the core motif may play a role in determining receptor selectivity. To address this issue, we used a combinatorial phage display approach to evaluate the role of flanking sequences in influencing these interactions. We sampled more than 10(8) variations of the core LXXLL motif with estradiol-activated estrogen receptor alpha (ERalpha) as a target and found three different classes of peptides. All of these peptides interacted with ERalpha in an agonist-dependent manner and disrupted ERalpha-mediated transcriptional activity when introduced into target cells. Using a series of ERalpha-mutants, we found that these three classes of peptides showed different interaction patterns from each other, suggesting that not all LXXLL motifs are the same and that receptor binding selectivity can be achieved by altering sequences flanking the LXXLL core motif. Most notable in this regard was the discovery of a peptide which, when overexpressed in cells, selectively disrupted ERbeta- but not ERalpha-mediated reporter gene expression. This novel ERbeta-specific antagonist may be useful in identifying and characterizing the ERbeta-regulated process in estradiol-responsive cells. In conclusion, using a combinatorial approach to define cofactor-receptor interactions, we have clearly been able to demonstrate that not all LXXLL motifs are functionally equivalent, a finding which suggests that it may be possible to target receptor-LXXLL interactions to develop receptor-specific antagonists.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10567548      PMCID: PMC84907          DOI: 10.1128/MCB.19.12.8226

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  51 in total

1.  Estrogen receptor (ER) modulators each induce distinct conformational changes in ER alpha and ER beta.

Authors:  L A Paige; D J Christensen; H Grøn; J D Norris; E B Gottlin; K M Padilla; C Y Chang; L M Ballas; P T Hamilton; D P McDonnell; D M Fowlkes
Journal:  Proc Natl Acad Sci U S A       Date:  1999-03-30       Impact factor: 11.205

2.  The orphan nuclear receptor SHP inhibits agonist-dependent transcriptional activity of estrogen receptors ERalpha and ERbeta.

Authors:  L Johansson; J S Thomsen; A E Damdimopoulos; G Spyrou; J A Gustafsson; E Treuter
Journal:  J Biol Chem       Date:  1999-01-01       Impact factor: 5.157

3.  Rapid detection of octamer binding proteins with 'mini-extracts', prepared from a small number of cells.

Authors:  E Schreiber; P Matthias; M M Müller; W Schaffner
Journal:  Nucleic Acids Res       Date:  1989-08-11       Impact factor: 16.971

4.  The estrogen receptor beta-isoform (ERbeta) of the human estrogen receptor modulates ERalpha transcriptional activity and is a key regulator of the cellular response to estrogens and antiestrogens.

Authors:  J M Hall; D P McDonnell
Journal:  Endocrinology       Date:  1999-12       Impact factor: 4.736

5.  Peptide antagonists of the human estrogen receptor.

Authors:  J D Norris; L A Paige; D J Christensen; C Y Chang; M R Huacani; D Fan; P T Hamilton; D M Fowlkes; D P McDonnell
Journal:  Science       Date:  1999-07-30       Impact factor: 47.728

6.  Functional interactions of the AF-2 activation domain core region of the human androgen receptor with the amino-terminal domain and with the transcriptional coactivator TIF2 (transcriptional intermediary factor2).

Authors:  C A Berrevoets; P Doesburg; K Steketee; J Trapman; A O Brinkmann
Journal:  Mol Endocrinol       Date:  1998-08

7.  Determinants of coactivator LXXLL motif specificity in nuclear receptor transcriptional activation.

Authors:  E M McInerney; D W Rose; S E Flynn; S Westin; T M Mullen; A Krones; J Inostroza; J Torchia; R T Nolte; N Assa-Munt; M V Milburn; C K Glass; M G Rosenfeld
Journal:  Genes Dev       Date:  1998-11-01       Impact factor: 11.361

8.  The structural basis of estrogen receptor/coactivator recognition and the antagonism of this interaction by tamoxifen.

Authors:  A K Shiau; D Barstad; P M Loria; L Cheng; P J Kushner; D A Agard; G L Greene
Journal:  Cell       Date:  1998-12-23       Impact factor: 41.582

9.  Ligand binding and co-activator assembly of the peroxisome proliferator-activated receptor-gamma.

Authors:  R T Nolte; G B Wisely; S Westin; J E Cobb; M H Lambert; R Kurokawa; M G Rosenfeld; T M Willson; C K Glass; M V Milburn
Journal:  Nature       Date:  1998-09-10       Impact factor: 49.962

Review 10.  The steroid and thyroid hormone receptor superfamily.

Authors:  R M Evans
Journal:  Science       Date:  1988-05-13       Impact factor: 47.728

View more
  109 in total

1.  Domain structure of the NRIF3 family of coregulators suggests potential dual roles in transcriptional regulation.

Authors:  D Li; F Wang; H H Samuels
Journal:  Mol Cell Biol       Date:  2001-12       Impact factor: 4.272

2.  The transcription factor B-Myb is maintained in an inhibited state in target cells through its interaction with the nuclear corepressors N-CoR and SMRT.

Authors:  Xiaolin Li; Donald P McDonnell
Journal:  Mol Cell Biol       Date:  2002-06       Impact factor: 4.272

3.  Novel mechanism of nuclear receptor corepressor interaction dictated by activation function 2 helix determinants.

Authors:  Anna N Moraitis; Vincent Giguère; Catherine C Thompson
Journal:  Mol Cell Biol       Date:  2002-10       Impact factor: 4.272

4.  The cocaine- and amphetamine-regulated transcript mediates ligand-independent activation of ERα, and is an independent prognostic factor in node-negative breast cancer.

Authors:  D J Brennan; D P O'Connor; H Laursen; S F McGee; S McCarthy; R Zagozdzon; E Rexhepaj; A C Culhane; F M Martin; M J Duffy; G Landberg; L Ryden; S M Hewitt; M J Kuhar; R Bernards; R C Millikan; J P Crown; K Jirström; W M Gallagher
Journal:  Oncogene       Date:  2011-12-05       Impact factor: 9.867

5.  Hormone binding and co-regulator binding to the glucocorticoid receptor are allosterically coupled.

Authors:  Samuel J Pfaff; Robert J Fletterick
Journal:  J Biol Chem       Date:  2010-03-24       Impact factor: 5.157

6.  The actin-binding protein, actinin alpha 4 (ACTN4), is a nuclear receptor coactivator that promotes proliferation of MCF-7 breast cancer cells.

Authors:  Simran Khurana; Sharmistha Chakraborty; Xiwen Cheng; Yu-Ting Su; Hung-Ying Kao
Journal:  J Biol Chem       Date:  2010-11-15       Impact factor: 5.157

7.  In search of novel drug target sites on estrogen receptors using RNA aptamers.

Authors:  Daiying Xu; Vamsee-Krishna Chatakonda; Antonis Kourtidis; Douglas S Conklin; Hua Shi
Journal:  Nucleic Acid Ther       Date:  2014-03-03       Impact factor: 5.486

8.  A "cross-stitched" peptide with improved helicity and proteolytic stability.

Authors:  Thomas E Speltz; Christopher G Mayne; Sean W Fanning; Zamia Siddiqui; Emad Tajkhorshid; Geoffrey L Greene; Terry W Moore
Journal:  Org Biomol Chem       Date:  2018-05-23       Impact factor: 3.876

9.  Coregulator control of androgen receptor action by a novel nuclear receptor-binding motif.

Authors:  Katja Jehle; Laura Cato; Antje Neeb; Claudia Muhle-Goll; Nicole Jung; Emmanuel W Smith; Victor Buzon; Laia R Carbó; Eva Estébanez-Perpiñá; Katja Schmitz; Ljiljana Fruk; Burkhard Luy; Yu Chen; Marc B Cox; Stefan Bräse; Myles Brown; Andrew C B Cato
Journal:  J Biol Chem       Date:  2014-02-12       Impact factor: 5.157

10.  27-hydroxycholesterol is an endogenous selective estrogen receptor modulator.

Authors:  Carolyn D DuSell; Michihisa Umetani; Philip W Shaul; David J Mangelsdorf; Donald P McDonnell
Journal:  Mol Endocrinol       Date:  2007-09-13
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.